These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23382148)

  • 1. Opioid dependence and NMDA receptors.
    Glass MJ
    ILAR J; 2011; 52(3):342-51. PubMed ID: 23382148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal.
    Anderson EM; Reeves T; Kapernaros K; Neubert JK; Caudle RM
    J Pharmacol Exp Ther; 2015 Dec; 355(3):496-505. PubMed ID: 26377910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of glutamate in physical dependence on opioids.
    Zhu H; Rockhold RW; Ho IK
    Jpn J Pharmacol; 1998 Jan; 76(1):1-14. PubMed ID: 9517399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.
    Herman BH; Vocci F; Bridge P
    Neuropsychopharmacology; 1995 Dec; 13(4):269-93. PubMed ID: 8747752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the role of glutamate within the locus coeruleus during the development of opioid dependence and on the expression of withdrawal from dependence on opioids].
    Tokuyama S; Takahashi M; Yamamoto T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):141-7. PubMed ID: 11215398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.
    Wang Y; Yin F; Guo H; Zhang J; Yan P; Lai J
    Int J Neuropsychopharmacol; 2017 Jul; 20(7):562-574. PubMed ID: 28199666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate physical dependence and N-methyl-D-aspartate receptors.
    Noda Y; Nabeshima T
    Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets.
    Rehni AK; Jaggi AS; Singh N
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):112-25. PubMed ID: 23244430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists.
    Bisaga A; Popik P
    Drug Alcohol Depend; 2000 Apr; 59(1):1-15. PubMed ID: 10706971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
    Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
    Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
    Zhao M; Joo DT
    Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate in opioid dependence.
    Ho IK; Feng YZ; Tokuyama S; Hoshi K; Rockhold RW
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Aug; 17(4):175-80. PubMed ID: 9365966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blockade of opioid tolerance and dependence by NMDA receptor antagonist].
    Zang MW; Liu JS
    Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):207-13. PubMed ID: 12532781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence.
    Trujillo KA
    Neuropsychopharmacology; 1995 Dec; 13(4):301-7. PubMed ID: 8747754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous opioid system: a promising target for future smoking cessation medications.
    Norman H; D'Souza MS
    Psychopharmacology (Berl); 2017 May; 234(9-10):1371-1394. PubMed ID: 28285326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotional Impairment and Persistent Upregulation of mGlu5 Receptor following Morphine Abstinence: Implications of an mGlu5-MOPr Interaction.
    Zanos P; Georgiou P; Gonzalez LR; Hourani S; Chen Y; Kitchen I; Kieffer BL; Winsky-Sommerer R; Bailey A
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26861145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
    Elliott K; Kest B; Man A; Kao B; Inturrisi CE
    Neuropsychopharmacology; 1995 Dec; 13(4):347-56. PubMed ID: 8747759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain, opioids, and sleep: implications for restless legs syndrome treatment.
    Trenkwalder C; Zieglgänsberger W; Ahmedzai SH; Högl B
    Sleep Med; 2017 Mar; 31():78-85. PubMed ID: 27964861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress.
    Abdel-Zaher AO; Abdel-Rahman MS; Elwasei FM
    Neurotoxicology; 2011 Dec; 32(6):725-33. PubMed ID: 21855572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.